Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2Neoplasm Metastasis 2Breast Neoplasms 2Vaping 1Tobacco Use Disorder 1Stomach Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1Granulosa Cell Tumor 1Endometrial Neoplasms 1Abiraterone Acetate 1

Interventions

Tobacco Use Cessation Devices 7Counseling 6Varenicline 4Nicotine Replacement Therapy 3Early Intervention, Educational 3Community Health Workers 3Bupropion 3Surveys and Questionnaires 2phenethyl isothiocyanate 1phenanthrene tetraol 1phenanthrene 1Zinc Oxide 1Spectrometry, Fluorescence 1Radiotherapy 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Optical Imaging 1Nicotine Chewing Gum 1Nicotine 1Molecular Diagnostic Techniques 1Methods 1Memantine 1Gene Expression Profiling 1Fertility 1Ethanol 1Endoscopic Mucosal Resection 1Drug Therapy 1Chemoradiotherapy 1Calcitriol 1BID protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Tobacco Use Disorder × BID protein, human × Clear all
NCT07040566 2025-12-17

A Trial of Varenicline for E-cigarette Cessation

Yale University

Phase 2 Recruiting
326 enrolled

Vaping, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡